| IPR2021-00402 | Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc. | Jan 7, 2021 |
| PGR2021-00035 | Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc. | Jan 7, 2021 |
| IPR2022-01226 | Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Jul 1, 2022 |
| 1:22-cv-00061 | Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. | Aug 2, 2022 |
| IPR2023-00462 | Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Jan 17, 2023 |
| IPR2023-00566 | Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. | Feb 10, 2023 |
| IPR2023-00533 | Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Feb 10, 2023 |
| IPR2023-00739 | Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. | Mar 26, 2023 |
| IPR2023-01312 | Samsung Bioepis Co., Ltd. v. REGENERON PHARMACEUTICALS, INC. | Aug 18, 2023 |
| IPR2024-00201 | Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc. | Nov 20, 2023 |
| 1:23-cv-00094 | Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD., | Nov 21, 2023 |
| 1:23-cv-00106 | Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd. | Dec 27, 2023 |
| 2:24-cv-00264 | Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. | Jan 10, 2024 |
| 1:24-cv-00053 | Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. | May 17, 2024 |
| 3:24-cv-08760 | Regeneron Pharmaceuticals, Inc. v. SANDOZ INC. | Aug 26, 2024 |
| 2:24-cv-08760 | REGENERON PHARMACEUTICALS, INC. v. SANDOZ INC. | Aug 26, 2024 |
